CHINA MEDICAL UNIVERSITY HOSPITAL
🇹🇼Taiwan
Sugammadex and Time to Extubation in Ophthalmic Surgery
Completed
- Conditions
- General Anesthesia Using Endotracheal IntubationOphthalmologic Surgical ProcedureSugammadexNeostigmineExtubation Readiness
- Interventions
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 262
- Registration Number
- NCT06632067
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Exploring the Impact of VR-based Acupuncture Treatment on Patient Experience and Doctor-patient Interaction.
Not Applicable
Not yet recruiting
- Conditions
- AcupunctureVirtual Reality
- Interventions
- Device: Virtual Reality
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06620224
The Clinical Research of Auricular Magnet for Anorexia in Children
Not Applicable
Recruiting
- Conditions
- Anorexia in Children
- Interventions
- Other: Auricular magnet with a magnetic strength of 1800 GaussOther: Auricular magnet with no magnetic strength
- First Posted Date
- 2024-09-30
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 144
- Registration Number
- NCT06619548
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections
Not Applicable
Recruiting
- Conditions
- IncontinenceUrinary Tract InfectionIncontinence-associated DermatitisCost-effectiveness
- Interventions
- Device: AI-supporter
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-09-26
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06613503
- Locations
- 🇨🇳
Rom A Master List, Extracted From This Organization'S Records., Taichung, Taiwan
Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT
Phase 2
Not yet recruiting
- Conditions
- Locally Advanced Unresectable Esophageal Cancer
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06598917
Evaluation of Astaxanthin Properties on Anti-fatigue
Not Applicable
Completed
- Conditions
- Healthy Volunteer
- Interventions
- Other: Placebo (Placebo trial)Other: Astaxanthin (AST trial)
- First Posted Date
- 2024-09-12
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06593535
- Locations
- 🇨🇳
China Medical University, Taichung, Taiwan
Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease Patients
Not Applicable
- Conditions
- Chronic Kidney DiseasesProteinuriaDiabetes Mellitus
- Interventions
- Device: On-venous Laser Irradiation of BloodDevice: low dose On-venous Laser Irradiation of Blood
- First Posted Date
- 2024-09-09
- Last Posted Date
- 2024-09-09
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT06588465
- Locations
- 🇨🇳
China Medical University Hospital, Taichung City, North Dist, Taiwan
ADSCs Therapy in Patients With CTD-ILD
Phase 1
Recruiting
- Conditions
- Interstitial Lung DiseaseConnective Tissue Diseases
- Interventions
- Biological: ADSC01
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT06574581
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Accuracy and User Performance Evaluation of PixoTest HbA1c Measurement System
Not Applicable
Completed
- Conditions
- HbA1cDiabetes
- Interventions
- Diagnostic Test: in-vitro
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06575231
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
Phase 2
Recruiting
- Conditions
- Schizophrenia
- Interventions
- Drug: S1RA plus NMDAEDrug: S1RA plus Placebo Cap
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT06574360
- Locations
- 🇨🇳
Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan
© Copyright 2025. All Rights Reserved by MedPath